CD8A and melanoma: He et al. transferred Ezh2fl/flCd4Cre Pmel CD8+ T cells into melanoma B16-tumor-bearing mice, and showed that these cells were incapable of mediating the same tumor growth inhibition as Ezh2-sufficient cells (29).